Signal
23 articles covering "neuroscience"
A Shanghai-built AAV gene therapy delivering two dopamine-synthesis genes to the putamen was safe in 10 patients, with motor improvements at one year.
ETH Zurich researchers report that aggregates of inactivated GRK2 choke mitochondria and fuel amyloid beta, and that an experimental molecule, compound 10, slowed nerve cell death in mice.
A Nature Communications study used simultaneous EEG-fMRI to show that early sleep suppresses light responses in the visual cortex while the thalamus stays intact.
A machine-learning analysis of sleep EEG data from 7,105 adults found that each 10-year gap between brain age and chronological age raises dementia risk by 39%.
An AAV9 gene-regulation therapy delivered durable, dose-dependent seizure control and early signs of neurodevelopmental rescue through 52 weeks, just as the pivotal study begins dosing.
CorTec's implantable Brain Interchange system received FDA Breakthrough Device Designation on April 8 and TAP acceptance on April 23, marking the first BCI worldwide designated for stroke motor rehabilitation.
Researchers at Northwestern University have used aerosol jet printing to create flexible artificial neurons that generate biologically realistic signals and directly activate living neural tissue.
University of Illinois researchers publish Connectome-seq in Nature Methods, using RNA barcodes to map over 1,000 neurons at single-synapse resolution and uncover previously unknown connectivity patterns in the mouse brain.
MRI imaging and tissue analysis reveal that the middle meningeal artery hosts an organized lymphatic network responsible for brain waste removal, with implications for Alzheimer's research.
A Nature Neuroscience study from the Montreal Neurological Institute constructs the first whole-brain atlas of 14 neuropeptide families, uncovering a cortical-subcortical gradient and evidence that neuropeptide refinement coincided with the evolutionary emergence of the neocortex.
A decade after the first lab-grown brain models, organoid research is crossing from laboratory curiosity to clinical reality, prompting calls for governance frameworks to match the pace of science.
Epia Neuro emerged from stealth on April 2 with a read/write BCI platform that decodes neural intent and drives a grip-assist prosthetic, targeting first-in-human trials at Lenox Hill Hospital later this year.